Post on 27-Dec-2014
description
© Innova Biosciences ltd. 2012. All rights reserved
in association with
For a full recording of the webinar please visit: www.innovabiosciences.com/videos.html
© Innova Biosciences ltd. 2012. All rights reserved
A Beginner’s Guide to
Lateral Flow Assay Development
© Innova Biosciences ltd. 2012. All rights reserved
Dr. Ahmed Jehanli, IPRO Interactive Ltd
Antibody and Antigen Selection for Lateral Flow Tests Dr. Klaus Hochleitner, GE Healthcare Life Sciences
Lateral Flow Rapid Tests: Material Selection, Material Properties and Basic Troubleshooting Tom Speedy, Innova Biosciences Ltd
Covalent attachment of antibodies and ligands to gold nanoparticles
© Innova Biosciences ltd. 2012. All rights reserved
Antibody and Antigen Selection for Lateral Flow Tests
Ahmed Jehanli
IPRO Interactive Ltd
Oxfordshire, UK
Ahmed.jehanli@iprointeractive.com
© Innova Biosciences ltd. 2012. All rights reserved
Introduction
• Lateral flow (LF) immunoassays point-of-contact tests are simple to use, provide rapid results with minimum amount of sample preparation
• Lateral flow immunoassays underwent huge expansion following the development of rapid pregnancy tests in the 70s
• LF tests are widely available in the medical, veterinary, environmental, and other fields.
• Global market in billions of dollars
© Innova Biosciences ltd. 2012. All rights reserved
Basic Components of Lateral flow test
• Membrane strip/ test site
• Sample pad
• Conjugate (detector) pad
• Absorbent (sink) pad
• Antibody and antigen reagents
© Innova Biosciences ltd. 2012. All rights reserved
Lateral Flow test Types:
• Sandwich assay format: Used for large analytes (proteins) with multiple antigenic determinants
• Competitive assay format: Used for small molecules (hormones, drugs, etc
© Innova Biosciences ltd. 2012. All rights reserved
Sandwich LF Assay
Double antibody sandwich for antigen detection
Sandwich assay for antibody detection
Detector label
Detector antibody
analyte
© Innova Biosciences ltd. 2012. All rights reserved
Competitive Inhibition LF Assay
Analyte negative sample Analyte positive sample
Carrier molecule with covalently attached analyte, e.g. BSA-cortisol
© Innova Biosciences ltd. 2012. All rights reserved
Antibodies Polyclonal
• Advantages:
– High affinity
– Wide choice of species
• Disadvantages:
– Purity of the antigen is essential to achieve high specificity
– Less than 5% of the immunoglobulin fraction will be the wanted antibody. Immunoaffinity purification is essential
– Supply is limited
Monoclonal
• Advantages:
– Unlimited supply
– High specificity
– Immunoaffinity purification is not necessary.
• Disadvantages:
– High affinity antibodies can be difficult to achieve
– Limited choice of species (murine monoclonal antibodies)
© Innova Biosciences ltd. 2012. All rights reserved
Source of Antibodies & Antigens
• Commercial sources: – Use antibody data bases for searching for reagents, e.g.,
Biocompare.com, Linscott’s Directory
– Antigen-antibody pairing are available for cardiac markers, steroids, drugs of abuse, etc. Many already designed for lateral flow assays
– Must ensure that continuous supply of reagents can be provided
© Innova Biosciences ltd. 2012. All rights reserved
Source of Antibodies & Antigens
• In House: – Several companies exist for carrying out contract immunisation and
antibody production both poly- and mono-clonal
– For polyclonal antibodies, rabbit, sheep, goat and chicken can be used
– For monoclonal antibodies, murine is the choice. Other species monoclonal antibody production is available but can be costly and royalty payments might be expected. For sheep monoclonal antibodies see Bioventix PLC
– Recombinant and engineered antibodies are not widely commercially available and tend to be costly
© Innova Biosciences ltd. 2012. All rights reserved
Immunisation • Antigens:
– Purity of the antigen used for immunisation is crucial for raising polyclonal antibodies but not so for monoclonal antibodies
– In general, molecules over 5000 molecular weight can be used for immunisation with out further treatment
– If the antigen is not very immunogenic, treat as a “hapten” and conjugate it with a “carrier” molecule, KLH for immunisation, example platelet derived growth factor (PDGF)
– Small molecules (haptens) like hormones, drugs and small peptides must be covalently attached to a large “carrier” protein prior to immunisation. Substitution ratio of the hapten: protein has an impact on the affinity of the raised antibody
– Type of spacer used to link the hapten to the carrier can have an effect on the nature of antibody specificity
– Avoid using BSA or OVA as carriers as both are commonly used in LF assays as blocking agents
© Innova Biosciences ltd. 2012. All rights reserved
Antibody Evaluation
• Prior to setting up the LF assay, evaluate reagents using enzyme immunoassays (EIA) (sandwich or competitive inhibition depending on the antigen). Validate, the specificity, sensitivity and matrix suitability of the reagents.
• Although LF assays also use Sandwich and competitive formats they are different from EIAs. The former format is an “open” system while the latter is a “closed” system.
• It is very important that the analyte matrix is introduced to the LF evaluation very early in assay development.
Don’t waste too much time on validation work in buffers.
© Innova Biosciences ltd. 2012. All rights reserved
Major Issues with LF Assays
Sensitivity & non-specific signal
Can be dealt with by changing antibody-gold particle substitution ratio, signal amplification, amount of
reagents deposited on the membrane, and sample buffer components
© Innova Biosciences ltd. 2012. All rights reserved
Conclusion
• The quality of the antibody and antigen used in LF is very important
• Antibody affinity and specificity is very critical for a successful LF assay.
• Purity and type of antigen used in the LF assay can impact on assay sensitivity and specificity especially for competitive inhibition assays
© Innova Biosciences ltd. 2012. All rights reserved
Lateral Flow Rapid Tests: Material Selection, Material Properties and Basic Troubleshooting Dr. Klaus Hochleitner Global Lead Technical Product Specialist Diagnostics GE Healthcare Life Sciences Contact: Klaus.Hochleitner@ge.com
© Innova Biosciences ltd. 2012. All rights reserved
Sample
Self-Adhesive
Plastic Support
Sample Pad:
Sample
Preparation Conjugate Pad:
Sample meets
Detection Reagents
NC Membrane:
Bind the target
See the result
Absorbent Paper:
Dispose remaining
sample liquid
Not shown: Tapes,
Housings, Packaging Materials Reagents, Dispensing Equipment, Result Analysis
The Typical Rapid Test: A Lateral Flow Device
© Innova Biosciences ltd. 2012. All rights reserved
Sample pad selection: What do you need to know about your sample before?
• Variability of target molecule concentration (defines sample volume to be applied).
• Variability of sample composition, e.g. pH (sample composition may have to be adjusted by sample pad pretreatment).
• Sample viscosity (limits density of the pad material).
• Unspecific interactions of your target with the pad material (defines pad blocking requirements).
• Unspecific interactions of the target with test line reagents (may require additional adjustments).
• Need of retention of particles contained in the sample (e.g. red blood cells).
© Innova Biosciences ltd. 2012. All rights reserved
Sample Pad Selection
• Specify sample volume to be applied on test strip.
• GE provides material properties (absorption capacity in µl/cm², paper raw materials, presence of binders).
• Select high quality chromatography paper as sample pad, if possible made of cotton linters (the most reproducible paper raw material).
• If the sample pad is to retain particles, especially red blood cells, or is to serve as a combined sample and conjugate pad, select a glass fiber pad material.
© Innova Biosciences ltd. 2012. All rights reserved
Sample Pad Pretreatment • Usually done by immersion. • Dry material in a forced air convection oven. • Store the coated material at 18 – 25°C and less than 20% rel. humidity.
Holds true for ALL coated materials in lateral flow tests!
Pretreatment buffer:
pH adjustment (always necessary)
Salts (try to avoid or use low concentrations)
Blockers (proteins, polymers as e.g. PVP, PVA, PEG)
Nonionic surfactants (increase wettability of pad material, support blocking, may help to reduce unspecificities)
Beware of hemolytic reagents if blood is your sample
© Innova Biosciences ltd. 2012. All rights reserved
Blood Samples: Retention of RBCs
Cells are retained by mechanical interaction
Wrap around fibers
General Recommendations: • Define blood volume to be applied very carefully, and select appropriate pad
– too much volume leads to red blood cell breakthrough problems! • Avoid hemolysis as this will release free hemoglobin to your membrane
which will result in a background color difficult to deal with.
© Innova Biosciences ltd. 2012. All rights reserved
The Conjugate pad: Basic Considerations
• Typically, it is the physically smallest part in a lateral flow test. • Fulfills a diversity of functions:
• Absorbs the volume in which the detector conjugate is added to the pad. • Does not interact with the conjugate. • Maintains the conjugate integrity upon drying. • Maintains the conjugate integrity in the dry state
(can easily be more than a year at “room temperature“). • Releases the conjugate easily and completely upon contact with the
sample liquid. • Allows for interaction between the detector reagents in the conjugate
and the target in the sample.
© Innova Biosciences ltd. 2012. All rights reserved
Conjugate pad selection: What do you need to know before?
• Type of conjugate do you want to use (Metal colloids, latex beads, covalent or non-covalent binding of the detector molecules to the particle, no use of particles but directly labeled antibodies/antigens).
• Amount of detector molecules needed in a test in order to obtain the required sensitivity.
• Maximum concentration that can be achieved with the conjugate in solution without inducing aggregation of particles.
• As a result of these considerations: What is the volume of conjugate solution that must be applied to the conjugate pad per test?
Define the absorption capacity required per cm² of pad. Select the pad material. Calculate the pad size needed per test.
© Innova Biosciences ltd. 2012. All rights reserved
Conjugate Pad Materials
• Options are glass fiber pads and non-wovens. • Glass fibers are more versatile, especially when it comes to additional pad
functions as e.g. sample application or RBC retention. • In general, glass fibers are recommended.
Pretreatment of Conjugate Pads
pH adjustment (always necessary)
Do not use salts (especially metal colloids are not compatible with high salt concentrations)
Blockers (proteins, polymers as e.g. PVP, PVA, PEG)
Nonionic surfactants (wettability, pad blocking, membrane blocking “on the fly“).
© Innova Biosciences ltd. 2012. All rights reserved
How To Get The Conjugate Into The Pad
Two options: - Immersion/dipping of the pad in a conjugate solution - Dispensing of defined conjugate volumes per conjugate pad length/area Drawback of Immersion/Dipping: - The pad material is variable in thickness. Soaking the pads with
conjugate will lead to variable amounts of conjugate in the tests strips manufactured, and may lead to poor test reproducibility.
Drawback of Dispensing: - Equipment needed Strong recommendation: Dispense!
© Innova Biosciences ltd. 2012. All rights reserved
The Analytical Membrane
• Typically, this is a “large pore sized“ nitrocellulose (NC) membrane. • The membranes are available in a very broad range of sample flow characteristics. • All NC membranes contain a surfactant, usually an anionic surfactant, that makes
them hydrophilic.
© Innova Biosciences ltd. 2012. All rights reserved
The Structure of NC Membranes
• NC Membranes do not have “pores“. • They are made of a meshwork of NC fibres:
drag and drop picture here
1000x
SEM FF 120 HP, 1000 x magnification
© Innova Biosciences ltd. 2012. All rights reserved
Characterization of NC Membranes: Capillary Flow Time
Describes the time a liquid (water) needs to migrate a defined distance (4 cm) parallel to the membrane surface against gravity.
Test procedure:
Strip width: 10 mm
Water volume: 100µl
Typical Membrane Specifications:
Description Capillary Flow
FF80 HP 60 – 100 seconds
FF120HP 90 – 150 seconds
FF170HP 140 – 200 seconds
© Innova Biosciences ltd. 2012. All rights reserved
Membrane Selection • Parameters to consider are sample type, test duration, and membrane
variability. • The more viscous a sample the slower it will run through a membrane. • The slower a membrane, the more NC it contains per cm² surface area which
means that it can bind more protein and generates more sensitive tests • Especially for highly sensitive and/or quantitative tests, use membranes with
very low CVs on capillary flow times.
A general recommendation for test development:
Sample type Recommended Membrane Characteristics
Water Slow membrane as eg. FF 170 HP
Urine; low blood/serum volume with chase buffer
Medium fast membrane as eg. FF 120 HP
Undiluted serum; saliva; resolubilized solids Fast membrane as eg. FF 80 HP
Please note that the reagent quality has a massive influence on the membrane selection.
© Innova Biosciences ltd. 2012. All rights reserved
Dispensing Protein Lines
General recommendations: • Use precision dispensing equipment as early as possible in test development. • Typical dispensing rates are varying between 0.6 µl/cm and more than
1 µl/cm. • Typical protein concentrations are varying between 0.75 and 1.25 µg/µl. • Apply proteins to the membrane in a buffer close to the protein‘s pI. • The buffer should not contain high salt concentrations. • The buffer may contain a low concentration of methanol or ethanol
(up to 3 % v/v). • Try to avoid the use of surfactants – they may lead to foaming problems
while being dispensed on the membrane. • Low concentrations of Trehalose (recommendation: 0.5 – 1 % w/v) are
sometimes used to increase the stability of the protein of the membrane surface.
© Innova Biosciences ltd. 2012. All rights reserved
The Wick
• Its task is to soak the sample liquid and all reagents that have not been absorbed at the test and control lines.
• It must prevent the backflow of this liquid into the drying membrane as long as possible.
• Select a cotton linters paper with an absorption capacity that is much higher than the sample volume.
© Innova Biosciences ltd. 2012. All rights reserved
Some Basic Troubleshooting Issue Possible Solution
Uneven Lines/Dots Use Membrane with different pore size,
Reduce dispensing volume of reagent,
Increase protein concentration of reagent
Check dispensing buffer composition
Check dispensing process
False positive signals Modify buffer in conjugate pad/solution:
- pH, - salt concentration, - surfactant conc.,
Change conjugated protein
False negative signals See above,
Also: Use membrane with smaller pore size,
Increase sample volume
Uneven liquid fronts of migrating
sample
Check membrane shelf life,
Use membrane with different/more surfactant,
Check relative humidity (very low?),
Contact membrane supplier (membrane
surface properties?),
Increase surfactant conc. in conjugate pad
© Innova Biosciences ltd. 2012. All rights reserved
“GE, imagination at work and GE monogram are trademarks of General Electric Company” “All goods and services are sold subject to the terms and conditions of sale of the company within GE Healthcare which supplies them. A copy of these terms and conditions is available on request. Contact your local GE Healthcare representative for the most current information” “© 2011 †General Electric Company – All rights reserved. First published April. 2012‡” “GE Healthcare UK Limited Amersham Place Little Chalfont Buckinghamshire. HP7 9NA UK” “Manufactured under a license to DE 10102744 and foreign equivalents thereof” Regulatory Note: This is a technical report and the data contained within is not intended to support any shelf life claims made for the product in the instructions for use.
© Innova Biosciences ltd. 2012. All rights reserved
© Innova Biosciences ltd. 2012. All rights reserved
Covalent attachment of antibodies and ligands to gold nanoparticles
Tom Speedy – Corporate Business Manager
© Innova Biosciences ltd. 2012. All rights reserved
1.Innova Biosciences and bioconjugation
2.Traditional (passive) gold conjugation methods
3.Overview of covalent chemistries
4.Functionalisation of gold nanoparticles
5.Ultra-stable InnovaCoatTM GOLD nanoparticles
© Innova Biosciences ltd. 2012. All rights reserved
What is Lightning-Link® technology?
The worlds fastest, simplest and most efficient conjugation technology!
• Just 30 seconds hands-on time to set up the reaction • Over 50 labels available including: Enzymes, fluorescent proteins, fluorescent dyes, tandems, biotin & streptavidin
• 100% antibody recovery • Fully scalable from R&D to Production / Manufacture • Virtually eliminates batch to batch variability • Covalent conjugation ensures long term stability • Available as traditional Lightning-Link® (2 hour incubation) or new Lightning-
Link® RAPID (15 minute incubation)
© Innova Biosciences ltd. 2012. All rights reserved
The World’s fastest and easiest to use antibody labelling system
© Innova Biosciences ltd. 2012. All rights reserved
• 20 – 80nm gold used in diagnostic tests
• Antibody-gold conjugates made by a non-covalent (passive) adsorption technique
• Colloidal instability when attaching ligands or biomolecules to naked gold (or nanoparticles in general)
• Need to optimise conditions for each antibody (pH, salt conc. etc.), centrifuge..
© Innova Biosciences ltd. 2012. All rights reserved
Ratio 650:530 is an aggregation parameter
400 500 600 7000
20
40
60
80
100
Wavelength
Ab
so
rban
ce
aggregated
dispersed
© Innova Biosciences ltd. 2012. All rights reserved
Self assembly on planar gold surfaces:
thiol
alkanethiol
Au-S dative bond
carboxyl analogue
© Innova Biosciences ltd. 2012. All rights reserved
- -
- -
- - -
- -
-
- -
Citrate ions
destabilised
successful coating
dissociation
X + X = COOH or NH2
COOH or NH2
© Innova Biosciences ltd. 2012. All rights reserved
Gold
Latex
InnovaCoat surface
Colloidal stabilisation
Surface functionalisation
Control the number of reactive groups
© Innova Biosciences ltd. 2012. All rights reserved
COOH
amine
hydrazide
maleimide
epoxide
aldehyde
Amine, hydroxyl
Amines (lys) COOH (glu, asp)
aldehyde
Thiol (cys)
NHS esters
hydrazide
© Innova Biosciences ltd. 2012. All rights reserved
400 500 600 7000
20
40
60
80
1001M NaCl1M HCl1M NaOHWater
naked
InnovaCoat Gold(4 curves)
Wavelength
Ab
so
rban
ce
Enhanced colloidal stability
© Innova Biosciences ltd. 2012. All rights reserved
Conjugate Min (to aggregate) Biotin-Gold (competitor 1) <0.1
Biotin-Gold (competitor 2) <0.1
Carboxyl gold (competitor 3) (self assembly?) <0.1
Lipoid acid (self assembly) <0.1
Mercaptopropionic acid <0.1
Antibody/Naked gold (passive) ~5
Antibody-InnovaCoat™ (covalent) 170
InnovaCoat™ intermediates (e.g. carboxyl, amine) 90-150
InnovaCoat™ Biotin 150
InnovaCoat™ Streptavidin 120
Stability in 2.5M NaOH at 70°C
© Innova Biosciences ltd. 2012. All rights reserved
biotin biotin
Strep Ctrl Strip type: Strep Ctrl
© Innova Biosciences ltd. 2012. All rights reserved
A B C D
A - InnovaCoat GOLD 10 OD
B – Washed
C – Naked gold 10 OD
D – Naked gold washed
IgG spotted strips,
BSA blocked
Integrity of the surface coat
© Innova Biosciences ltd. 2012. All rights reserved
© Innova Biosciences ltd. 2012. All rights reserved
What is InnovaCoat® technology?
A revolutionary method for conjugating nanoparticles to biomolecules
• Proprietary surface coat • Ultra stable • Covalent linking of antibodies, analytes and other biomolecules • Increased assay sensitivity • NO pH titrations – NO centrifugations – NO aggregation or instability!
© Innova Biosciences ltd. 2012. All rights reserved
© Innova Biosciences ltd. 2012. All rights reserved
Increase your limits of detection with InnovaCoat GOLD
Figure 1. A comparison between the percentage binding of anti-cortisol antibodies conjugated to 40nm gold particles by a traditional passive method against those conjugated covalently using InnovaCoat technology. All components of this competitive lateral flow assay are identical with the exception of the method used to conjugate the antibodies to gold colloid. External data source.
0
10
20
30
40
50
60
70
80
90
100
0 0.2 0.4 0.6 0.8 1 1.2 1.4 1.6 1.8 2 2.2 2.4 2.6 2.8 3 3.2 3.4 3.6 3.8 4
% B
ind
ing
Cortisol Concentration [ng/mL]
InnovaCoat GOLD
Passive Gold Conjugation
© Innova Biosciences ltd. 2012. All rights reserved
Innovative Cambridge Company Innova Biosciences Secures Prestigious Development of Prototype Grant
from the Technology Strategy Board.
Innova Biosciences (Cambridge, UK), inventor of 'Lightning-Link®', the world’s easiest to use antibody labelling technology, is pleased to announce it has been awarded a development of prototype grant circa £210,000 by the Technology Strategy Board, with matched company funding of approximately £250,000, to develop novel nanoparticle products for diagnostics applications. Innova Biosciences Press Release: May 2012
© Innova Biosciences ltd. 2012. All rights reserved
Contact
If you would like any more information, please contact us at info@innovabiosciences.com
Please keep an eye out for our future webinars and other exciting news on our website and social media channels:
www.innovabiosciences.com/innova/webinars.html
YouTube: www.youtube.com/InnovaBiosciences
© Innova Biosciences ltd. 2012. All rights reserved
Innova Biosciences Ltd.
Babraham Research Campus,
Cambridge, UK,
CB22 3AT
www.innovabiosciences.com
Lightning-Link® is a registered trademark of Innova Biosciences